Connor, Clark & Lunn Investment Management (CC&L)’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,800
| Closed | -$388K | – | 1463 |
|
|
2024
Q1 | $388K | Buy |
+2,800
| New | +$388K | ﹤0.01% | 1190 |
|
|
2022
Q4 | – | Sell |
-30,118
| Closed | -$2.43M | – | 1272 |
|
|
2022
Q3 | $2.43M | Buy |
30,118
+11,205
| +59% | +$903K | 0.02% | 456 |
|
|
2022
Q2 | $1.41M | Buy |
18,913
+753
| +4% | +$56.1K | 0.01% | 543 |
|
|
2022
Q1 | $2.32M | Sell |
18,160
-13,176
| -42% | -$1.69M | 0.01% | 466 |
|
|
2021
Q4 | $4.21M | Buy |
31,336
+6,284
| +25% | +$843K | 0.02% | 363 |
|
|
2021
Q3 | $3.43M | Buy |
25,052
+7,584
| +43% | +$1.04M | 0.02% | 414 |
|
|
2021
Q2 | $1.87M | Sell |
17,468
-4,524
| -21% | -$483K | 0.01% | 554 |
|
|
2021
Q1 | $1.98M | Buy |
21,992
+1,008
| +5% | +$90.6K | 0.01% | 563 |
|
|
2020
Q4 | $1.94M | Buy |
20,984
+1,100
| +6% | +$102K | 0.01% | 515 |
|
|
2020
Q3 | $2.05M | Buy |
19,884
+2,332
| +13% | +$240K | 0.01% | 477 |
|
|
2020
Q2 | $1.78M | Buy |
+17,552
| New | +$1.78M | 0.01% | 480 |
|
|
2014
Q2 | – | Sell |
-70,000
| Closed | -$799K | – | 555 |
|
|
2014
Q1 | $799K | Buy |
70,000
+46,000
| +192% | +$525K | 0.01% | 418 |
|
|
2013
Q4 | $226K | Buy |
+24,000
| New | +$226K | ﹤0.01% | 647 |
|